# Preclinical Assessment of Investigational Cellular and Gene Therapy Products:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/preclinical-assessment-of-investigational-cellular-and-gene-therapy-products-guidance-for-industry/e4aedc4e-81e3-4d2e-b655-2460ccf3a04e

> FDA guidance document: Preclinical Assessment of Investigational Cellular and Gene Therapy Products:  Guidance for Industry. Issue date: November 01, 2013. Get complete insights and analysis.

---

## Details

- Title: Preclinical Assessment of Investigational Cellular and Gene Therapy Products:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2013-11-01
- Last Changed: 2025-02-03
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2012-D-1038">FDA-2012-D-1038</a>

## Related Documents

- [Current Good Tissue Practice (CGTP) and Additional Requirements for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps):  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/current-good-tissue-practice-cgtp-and-additional-requirements-for-manufacturers-of-human-cells-tissues-and-cellular-and-tissue-based-products-hctps-guidance-for-industry/5197b518-94ba-4445-b2d4-cccf3c8ac0e9)
- [Clinical Considerations for Therapeutic Cancer Vaccines:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-considerations-for-therapeutic-cancer-vaccines-guidance-for-industry/e0e6e4e0-a883-4f71-bf37-784e147d32d9)
- [Potency Tests for Cellular and Gene Therapy Products:  Final Guidance for Industry:](https://www.globalkeysolutions.net/guidances/guidance-document/potency-tests-for-cellular-and-gene-therapy-products-final-guidance-for-industry/59c72aad-aad2-413a-82eb-440ea6bc25f8)
